Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer
Conditions
Prostate CancerSummary
This will be a prospectively maintained research database. The purpose is to record baseline parameters and treatment outcomes following of Cryotherapy for ablation of clinically localized prostate cancer.
Locations
1 location Found with status Recruiting
Status
- RECRUITING
Central Contacts
- Majlinda Tafa
- (646) 825-6338
- [email protected]
Principal Investigator
- James Wysock, MD
Eligibility Criteria
Inclusion Criteria:
* Evidence of focal prostate cancer confined to the prostate based on MRI imaging and prostate biopsy
* Patients with clinically localized prostate cancer (no evidence for or concern for metastatic spread of cancer outside of the prostate) will be counseled regarding treatment options. Those selecting focal Cryo prostate ablation will then be offered inclusion into this data collection.
Exclusion Criteria:
* Men that are not diagnosed with prostate cancer.
* Men that are diagnosed with clinically localized prostate cancer, but select other treatment options as their desired treatment.
Study Plan
Men with Prostate Cancer
Men who receive cryotherapy for ablation of clinically localized prostate cancer.
Outcome Measures
Primary Outcome Measures
Treatment Complications
PSA-Progression Free Survival
Timeline
Last Updated
September 22, 2025Start Date
September 22, 2025Today
March 14, 2026Completion Date ( Estimated )
December 31, 2040
Sponsors of this trial
Lead Sponsor
NYU Langone Health